Rituximab as Rescue Therapy for Atezolizumab-Induced IgA Vasculitis
Cristina R Ortiz, Jose Arriola-Montenegro, Sanjeev Sethi, Sandra M Herrmann · 2026
Read Rituximab as Rescue Therapy for Atezolizumab-Induced IgA Vasculitis by Cristina R Ortiz, Jose Arriola-Montenegro, Sanjeev Sethi, Sandra M Herrmann (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13634387.txt.
Description
Cristina R Ortiz and three colleagues published this 2026 report of a kidney emergency triggered by a cancer immunotherapy drug. The drug, atezolizumab, frees the immune system to attack cancer, yet that freedom can turn immunity against healthy organs. A seventy-five-year-old man with advanced prostate cancer first developed a raised, purple rash after treatment. Kidney failure followed. A biopsy showed IgA vasculitis, an immune attack on small vessels, with aggressive inflammation inside the kidney's filters.
High-dose steroids brought only partial improvement, and body-wide inflammation persisted. The team then gave rituximab, which removes antibody-making B cells. Kidney function steadied, inflammatory markers normalized, and B cells vanished from his blood as intended. His cancer later advanced, yet the kidney gains held. The authors present the case, the first biopsy-proven one of its kind, as support for rituximab when steroids fall short.
Catalog record
| CREATOR | Cristina R Ortiz, Jose Arriola-Montenegro, Sanjeev Sethi, Sandra M Herrmann |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |